Croda International PLC Unsponsored ADR (OTCMKTS:COIHY) Sees Large Growth in Short Interest

Croda International PLC Unsponsored ADR (OTCMKTS:COIHY) saw a large increase in short interest during the month of July. As of July 15th, there was short interest totaling 862 shares, an increase of 1,467.3% from the June 30th total of 55 shares. Approximately 0.0% of the shares of the company are sold short. Based on an average daily trading volume, of 7,055 shares, the days-to-cover ratio is presently 0.1 days.

Croda International Stock Up 2.8%

OTCMKTS COIHY opened at $19.50 on Friday. The company has a current ratio of 1.99, a quick ratio of 1.18 and a debt-to-equity ratio of 0.21. The company has a 50 day moving average of $19.92 and a 200-day moving average of $19.53. Croda International has a 1-year low of $16.26 and a 1-year high of $22.29.

Analyst Upgrades and Downgrades

COIHY has been the topic of several research analyst reports. Kepler Capital Markets raised shares of Croda International from a “reduce” rating to a “hold” rating in a report on Tuesday, March 31st. Zacks Research upgraded Croda International from a “strong sell” rating to a “hold” rating in a research note on Monday, June 22nd. One investment analyst has rated the stock with a Strong Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy”.

Croda International Company Profile

Croda International plc is a UK-based specialty chemicals company headquartered in East Yorkshire, England. Established in 1925, Croda has built a global reputation for developing and manufacturing high-performance ingredients derived primarily from natural oils and renewable resources. The company’s research-driven approach has enabled it to innovate across a wide range of sectors, delivering solutions that combine efficacy, sustainability and compliance with stringent regulatory standards.

Croda’s operations are organized around three core segments: Personal Care, Life Sciences and Performance Technologies.